Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Dec;74(12):1862–1868. doi: 10.1038/bjc.1996.646

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

M Olivero 1, M Rizzo 1, R Madeddu 1, C Casadio 1, S Pennacchietti 1, M R Nicotra 1, M Prat 1, G Maggi 1, N Arena 1, P G Natali 1, P M Comoglio 1, M F Di Renzo 1
PMCID: PMC2074802  PMID: 8980383

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) stimulates the invasive growth of epithelial cells via the c-MET oncogene-encoded receptor. In normal lung, both the receptor and the ligand are detected, and the latter is known to be a mitogenic and a motogenic factor for both cultured bronchial epithelial cells and non-small-cell carcinoma lines. Here, ligand and receptor expression was examined in 42 samples of primary human non-small-cell lung carcinoma of different histotype. Each carcinoma sample was compared with adjacent normal lung tissue. The Met/HGF receptor was found to be 2 to 10-fold increased in 25% of carcinoma samples (P = 0.0113). The ligand, HGF/SF, was found to be 10 to 100-fold overexpressed in carcinoma samples (P < 0.0001). Notably, while HGF/SF was occasionally detectable and found exclusively as a single-chain inactive precursor in normal tissues, it was constantly in the biologically-active heterodimeric form in carcinomas. Immunohistochemical staining showed homogeneous expression of both the receptor and the ligand in carcinoma samples, whereas staining was barely detectable in their normal counterparts. These data show that HGF/SF is overexpressed and consistently activated in non-small-cell lung carcinomas and may contribute to the invasive growth of lung cancer.

Full text

PDF
1862

Images in this article

1864Figure 1
on p.1864
1865Figure 2
on p.1865
1865Figure 3
on p.1865
1865Figure 4
on p.1865
1866Figure 5
on p.1866

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ankrapp D. P., Bevan D. R. Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro. Cancer Res. 1993 Jul 15;53(14):3399–3404. [PubMed] [Google Scholar]
  2. Bellusci S., Moens G., Gaudino G., Comoglio P., Nakamura T., Thiery J. P., Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene. 1994 Apr;9(4):1091–1099. [PubMed] [Google Scholar]
  3. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Comoglio P. M. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. EXS. 1993;65:131–165. [PubMed] [Google Scholar]
  5. Cooper C. S., Park M., Blair D. G., Tainsky M. A., Huebner K., Croce C. M., Vande Woude G. F. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 1984 Sep 6;311(5981):29–33. doi: 10.1038/311029a0. [DOI] [PubMed] [Google Scholar]
  6. Defrances M. C., Wolf H. K., Michalopoulos G. K., Zarnegar R. The presence of hepatocyte growth factor in the developing rat. Development. 1992 Oct;116(2):387–395. doi: 10.1242/dev.116.2.387. [DOI] [PubMed] [Google Scholar]
  7. Di Renzo M. F., Narsimhan R. P., Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P. M. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991 Nov;6(11):1997–2003. [PubMed] [Google Scholar]
  8. Di Renzo M. F., Olivero M., Ferro S., Prat M., Bongarzone I., Pilotti S., Belfiore A., Costantino A., Vigneri R., Pierotti M. A. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene. 1992 Dec;7(12):2549–2553. [PubMed] [Google Scholar]
  9. Di Renzo M. F., Olivero M., Giacomini A., Porte H., Chastre E., Mirossay L., Nordlinger B., Bretti S., Bottardi S., Giordano S. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res. 1995 Feb;1(2):147–154. [PubMed] [Google Scholar]
  10. Di Renzo M. F., Olivero M., Katsaros D., Crepaldi T., Gaglia P., Zola P., Sismondi P., Comoglio P. M. Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer. 1994 Sep 1;58(5):658–662. doi: 10.1002/ijc.2910580507. [DOI] [PubMed] [Google Scholar]
  11. Giordano S., Ponzetto C., Di Renzo M. F., Cooper C. S., Comoglio P. M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 1989 May 11;339(6220):155–156. doi: 10.1038/339155a0. [DOI] [PubMed] [Google Scholar]
  12. Giordano S., Zhen Z., Medico E., Gaudino G., Galimi F., Comoglio P. M. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):649–653. doi: 10.1073/pnas.90.2.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. doi: 10.1073/pnas.90.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Iyer A., Kmiecik T. E., Park M., Daar I., Blair D., Dunn K. J., Sutrave P., Ihle J. N., Bodescot M., Vande Woude G. F. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ. 1990 Feb;1(2):87–95. [PubMed] [Google Scholar]
  15. Liu C., Tsao M. S. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Am J Pathol. 1993 Apr;142(4):1155–1162. [PMC free article] [PubMed] [Google Scholar]
  16. Liu G., Shuman M. A., Cohen R. L. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer. 1995 Feb 8;60(4):501–506. doi: 10.1002/ijc.2910600413. [DOI] [PubMed] [Google Scholar]
  17. Liu Y., Beedle A. B., Lin L., Bell A. W., Zarnegar R. Identification of a cell-type-specific transcriptional repressor in the promoter region of the mouse hepatocyte growth factor gene. Mol Cell Biol. 1994 Nov;14(11):7046–7058. doi: 10.1128/mcb.14.11.7046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mars W. M., Zarnegar R., Michalopoulos G. K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol. 1993 Sep;143(3):949–958. [PMC free article] [PubMed] [Google Scholar]
  19. Mason R. J., Leslie C. C., McCormick-Shannon K., Deterding R. R., Nakamura T., Rubin J. S., Shannon J. M. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol. 1994 Nov;11(5):561–567. doi: 10.1165/ajrcmb.11.5.7524567. [DOI] [PubMed] [Google Scholar]
  20. Masumoto A., Yamamoto N. Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. Biochem Biophys Res Commun. 1991 Jan 15;174(1):90–95. doi: 10.1016/0006-291x(91)90489-t. [DOI] [PubMed] [Google Scholar]
  21. Matsumoto K., Tajima H., Hamanoue M., Kohno S., Kinoshita T., Nakamura T. Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3800–3804. doi: 10.1073/pnas.89.9.3800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Matsumoto K., Tajima H., Okazaki H., Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J Biol Chem. 1992 Dec 15;267(35):24917–24920. [PubMed] [Google Scholar]
  23. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem. 1993 May 15;268(14):10024–10028. [PubMed] [Google Scholar]
  24. Miyazawa K., Shimomura T., Naka D., Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem. 1994 Mar 25;269(12):8966–8970. [PubMed] [Google Scholar]
  25. Mizuno K., Takehara T., Nakamura T. Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem Biophys Res Commun. 1992 Dec 30;189(3):1631–1638. doi: 10.1016/0006-291x(92)90264-l. [DOI] [PubMed] [Google Scholar]
  26. Moghul A., Lin L., Beedle A., Kanbour-Shakir A., DeFrances M. C., Liu Y., Zarnegar R. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene. 1994 Jul;9(7):2045–2052. [PubMed] [Google Scholar]
  27. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991 Nov 29;67(5):901–908. doi: 10.1016/0092-8674(91)90363-4. [DOI] [PubMed] [Google Scholar]
  28. Nagayama M., Sato A., Hayakawa H., Urano T., Takada Y., Takada A. Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer. 1994 Mar 1;73(5):1398–1405. doi: 10.1002/1097-0142(19940301)73:5<1398::aid-cncr2820730514>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  29. Naka D., Ishii T., Yoshiyama Y., Miyazawa K., Hara H., Hishida T., Kidamura N. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem. 1992 Oct 5;267(28):20114–20119. [PubMed] [Google Scholar]
  30. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992 Dec;11(13):4825–4833. doi: 10.1002/j.1460-2075.1992.tb05588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Naldini L., Vigna E., Bardelli A., Follenzi A., Galimi F., Comoglio P. M. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem. 1995 Jan 13;270(2):603–611. doi: 10.1074/jbc.270.2.603. [DOI] [PubMed] [Google Scholar]
  32. Naldini L., Weidner K. M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R. P., Hartmann G., Zarnegar R., Michalopoulos G. K. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 1991 Oct;10(10):2867–2878. doi: 10.1002/j.1460-2075.1991.tb07836.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Natali P. G., Nicotra M. R., Bigotti A., Venturo I., Slamon D. J., Fendly B. M., Ullrich A. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer. 1990 Mar 15;45(3):457–461. doi: 10.1002/ijc.2910450314. [DOI] [PubMed] [Google Scholar]
  34. Park M., Dean M., Cooper C. S., Schmidt M., O'Brien S. J., Blair D. G., Vande Woude G. F. Mechanism of met oncogene activation. Cell. 1986 Jun 20;45(6):895–904. doi: 10.1016/0092-8674(86)90564-7. [DOI] [PubMed] [Google Scholar]
  35. Plaschke-Schlütter A., Behrens J., Gherardi E., Birchmeier W. Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem. 1995 Jan 13;270(2):830–836. doi: 10.1074/jbc.270.2.830. [DOI] [PubMed] [Google Scholar]
  36. Prat M., Narsimhan R. P., Crepaldi T., Nicotra M. R., Natali P. G., Comoglio P. M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer. 1991 Sep 30;49(3):323–328. doi: 10.1002/ijc.2910490302. [DOI] [PubMed] [Google Scholar]
  37. Rong S., Segal S., Anver M., Resau J. H., Vande Woude G. F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4731–4735. doi: 10.1073/pnas.91.11.4731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rosell R., Li S., Skacel Z., Mate J. L., Maestre J., Canela M., Tolosa E., Armengol P., Barnadas A., Ariza A. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene. 1993 Sep;8(9):2407–2412. [PubMed] [Google Scholar]
  39. Rubin J. S., Chan A. M., Bottaro D. P., Burgess W. H., Taylor W. G., Cech A. C., Hirschfield D. W., Wong J., Miki T., Finch P. W. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):415–419. doi: 10.1073/pnas.88.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shimomura T., Miyazawa K., Komiyama Y., Hiraoka H., Naka D., Morimoto Y., Kitamura N. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem. 1995 Apr 1;229(1):257–261. doi: 10.1111/j.1432-1033.1995.tb20463.x. [DOI] [PubMed] [Google Scholar]
  41. Sonnenberg E., Meyer D., Weidner K. M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol. 1993 Oct;123(1):223–235. doi: 10.1083/jcb.123.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987 May 21;327(6119):239–242. doi: 10.1038/327239a0. [DOI] [PubMed] [Google Scholar]
  43. Tamura M., Arakaki N., Tsubouchi H., Takada H., Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem. 1993 Apr 15;268(11):8140–8145. [PubMed] [Google Scholar]
  44. Tang W., Miyazawa K., Kitamura N. Hepatocyte growth factor remains as an inactive single chain after partial hepatectomy or unilateral nephrectomy. FEBS Lett. 1995 Apr 3;362(2):220–224. doi: 10.1016/0014-5793(95)00251-4. [DOI] [PubMed] [Google Scholar]
  45. Tashiro K., Hagiya M., Nishizawa T., Seki T., Shimonishi M., Shimizu S., Nakamura T. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3200–3204. doi: 10.1073/pnas.87.8.3200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tsao M. S., Zhu H., Giaid A., Viallet J., Nakamura T., Park M. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ. 1993 Jul;4(7):571–579. [PubMed] [Google Scholar]
  47. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. doi: 10.1083/jcb.111.5.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Weidner K. M., Sachs M., Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol. 1993 Apr;121(1):145–154. doi: 10.1083/jcb.121.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yanagita K., Matsumoto K., Sekiguchi K., Ishibashi H., Niho Y., Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem. 1993 Oct 5;268(28):21212–21217. [PubMed] [Google Scholar]
  50. Yanagita K., Nagaike M., Ishibashi H., Niho Y., Matsumoto K., Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992 Jan 31;182(2):802–809. doi: 10.1016/0006-291x(92)91803-x. [DOI] [PubMed] [Google Scholar]
  51. Yu D., Wang S. S., Dulski K. M., Tsai C. M., Nicolson G. L., Hung M. C. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res. 1994 Jun 15;54(12):3260–3266. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES